PDAC (pancreatic ductal adenocarcinoma) is a highly aggressive malignant tumor. We have
previously developed induced tumor-suppressing cells (iTSCs) that secrete a group of tumor …

Osteosarcoma (OS) is the most frequent primary bone cancer, which is mainly suffered by
children and young adults. While the current surgical treatment combined with …

Simple Summary This study focused on finding effective anticancer peptides (ACPs) from
induced tumor-suppressing cells (iTSCs) to combat breast cancer metastasis to the skeletal …

The identification of tumor related membrane protein is important for both cancer diagnosis
and targeted therapy. Currently, the number of ideal clinical biomarkers is still limited …

Background Chromosome 16 open reading frame 74 (C16orf74) is highly expressed in
pancreatic ductal adenocarcinoma (PDAC) and is involved in cancer cell proliferation and …

Recently, we reported that anticancer bioactive peptide (ACBP), purified from goat spleens
immunized with human gastric cancer extracts, significantly inhibited gastric cancer cells in …

Cancer is a major public health concern requiring novel treatment approaches. Enzyme-
instructed self-assembly (EISA) provides a unique approach for selectively inhibiting cancer …

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related
death in western countries. The successful treatment of PDAC remains limited. We …

In the present study, the effective components of anticancer bioactive peptide‐3 (ACBP‐3), a
novel antitumor agent isolated from goat liver, were analyzed. The CD44 (+) fraction of the …

The combination of chemotherapeutic modalities may be more effective in treating gastric
cancer compared with any modality alone. Previous studies have demonstrated that the …